Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): final report.
Park HC, Kim YC, Kim H, Kim Y, Ryu HJ, Kim YS, Chung W, Kim YL, Han S, Jung Y, Shin HS, Na KY, Lee KB, Park HC, Han SH, Yoo TH, Kim YH, Kim SW, Lee KW, Kim SG, Lee CH, Bae KT, Oh KH, Ahn C, Oh YK.
Park HC, et al. Among authors: kim yh, kim h, kim yl, kim sw, kim sg, kim yc, kim ys, kim y.
Kidney Res Clin Pract. 2024 Sep 11. doi: 10.23876/j.krcp.24.067. Online ahead of print.
Kidney Res Clin Pract. 2024.
PMID: 39384353
Free article.